Bimagrumab improves body composition and insulin sensitivity in insulin‐resistant individuals

Abstract

Taking the observed changes together, and given that these occurred without accompanying dietary intervention and without any prescribed regular physical exercise, bimagrumab may offer a novel approach for the treatment of the metabolic complications of obesity.